BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Personalized medicine
,
Doxorubicin
,
rs7903146
,
FABP1
,
Angiogenesis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Lapatinib ditosylate
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CPVL
ID4
RBP4
SERPINA3
CYP4B1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
organic cyclic compound binding
heterocyclic compound binding
PUJANA_BRCA1_PCC_NETWORK
DODD_NASOPHARYNGEAL_CARCINOMA_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Lapatinib: A comprehensive profile.
The effect of shikonin on the metabolism of lapatinib in vitro, and in vivo.
Concurrent Lapatinib With Brain Radiation Therapy in Patients With HER2+ Breast Cancer With Brain Me…
Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of…
Macrophages M2 polarization is involved in lapatinib-mediated chemopreventive effects in the lung ca…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2…
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastati…
Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ